CURE Invest ApS: Financial statements 2018
CVR: 36495766
Source: annual report 2018, Danish Business Authority
01/01/2018 – 31/12/2018
CURE Invest ApS (CVR 36495766) has filed annual accounts for 2018. In 2018, the company reported a gross profit of DKK 0 and a net result of DKK 0 compared with DKK 0 the year before. Equity in the 2018 report amounted to DKK 1,249,994. The solvency ratio was 100%.
- Revenue
- DKK 0
- Gross Profit
- DKK 0
- Profit/Loss
- DKK 0
- Equity
- DKK 1,249,994
- Total Assets
- DKK 1,249,994
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2018 | 0 | 0 | 0 | 1.2M | - |
| 2017 | 0 | 0 | 0 | 1.2M | - |
| 2016 | 0 | 0 | 0 | 1.2M | - |
| 2015 | 0 | 0 | 6 | 1.2M | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2018
CURE Invest ApS has published its annual report for 2017. Revenue came to DKK 0, and the net result was DKK 0.
As of May 7, 2018, Sofie Møller Barkholt is registered as director of CURE Invest ApS.
As of May 7, 2018, Kenneth Nilsson has stepped down as director of CURE Invest ApS.
On May 7, 2018, the company changed its name from Holding 1980 ApS to CURE Invest ApS.
About CURE Invest ApS
CURE Invest ApS was a Danish company of the type Anpartsselskab based in Frederiksberg, founded in 2015. The company has been dissolved on 14 February 2024. The company was registered under the industry Anden finansiel formidling undtagen forsikring og pensionsforsikring, i.a.n.. The company was previously named Holding 1980 ApS and LAUGE BEK HOLDING ApS. In 2023, the company reported a gross profit of DKK 0 and a net result of DKK 0 compared with DKK 0 the year before. Equity in the 2023 report amounted to DKK 1,249,994.